Market News / Penny Stock News

Egalet Corp (NASDAQ:EGLT) Sentiment Change Report

Egalet Corporation (OTCMKTS:EGLT) Logo

Sentiment for Egalet Corp (NASDAQ:EGLT)

Egalet Corp (NASDAQ:EGLT) institutional sentiment increased to 0.93 in Q2 2018. Its up 0.23, from 0.7 in 2018Q1. The ratio has increased, as 13 funds increased or started new positions, while 14 sold and trimmed positions in Egalet Corp. The funds in our partner’s database reported: 7.42 million shares, down from 12.28 million shares in 2018Q1. Also, the number of funds holding Egalet Corp in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 9 Increased: 8 New Position: 5.

Egalet Corporation, a specialty pharmaceutical company, develops, makes, and commercializes treatments for patients with pain and other conditions. The company has market cap of $4.70 million. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It currently has negative earnings. The firm is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER.

The stock decreased 21.82% or $0.024 during the last trading session, reaching $0.086. About 169,042 shares traded. Egalet Corporation (NASDAQ:EGLT) has declined 74.44% since November 10, 2017 and is downtrending. It has underperformed by 90.06% the S&P500.

Analysts await Egalet Corporation (OTCMKTS:EGLT) to report earnings on November, 14. They expect $-0.21 EPS, up 54.35 % or $0.25 from last year’s $-0.46 per share. After $-0.17 actual EPS reported by Egalet Corporation for the previous quarter, Wall Street now forecasts 23.53 % negative EPS growth.

Highbridge Capital Management Llc holds 0.01% of its portfolio in Egalet Corporation for 1.48 million shares. Nj State Employees Deferred Compensation Plan owns 90,000 shares or 0.01% of their US portfolio. Moreover, Advisory Services Network Llc has 0% invested in the company for 1,835 shares. The Illinois-based Alyeska Investment Group L.P. has invested 0% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 4,296 shares.

Egalet Corporation (OTCMKTS:EGLT) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*